0001127602-21-025252.txt : 20210914
0001127602-21-025252.hdr.sgml : 20210914
20210914161423
ACCESSION NUMBER: 0001127602-21-025252
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210910
FILED AS OF DATE: 20210914
DATE AS OF CHANGE: 20210914
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ABERCROMBIE GEORGE B
CENTRAL INDEX KEY: 0001485939
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 211252544
MAIL ADDRESS:
STREET 1: C/O INSPIRE PHARMACEUTICALS, INC.
STREET 2: 4222 EMPEROR BLVD., SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-859-1302
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-09-10
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001485939
ABERCROMBIE GEORGE B
PO BOX 16069
CHAPEL HILL
NC
27516
1
Common Stock
2021-09-10
4
M
0
11000
1.71
A
14000
D
Common Stock
2021-09-10
4
M
0
30000
3.22
A
44000
D
Common Stock
2021-09-10
4
M
0
30000
2.91
A
74000
D
Common Stock
2021-09-10
4
S
0
74000
15.09
D
0
D
Automatic Stock Option Grant
1.71
2021-09-10
4
M
0
11000
0
D
2013-06-30
2023-05-31
Common Stock
11000
0
D
Automatic Stock Option Grant
3.22
2021-09-10
4
M
0
30000
0
D
2016-06-23
2026-05-23
Common Stock
30000
0
D
Automatic Stock Option Grant
2.91
2021-09-10
4
M
0
30000
0
D
2020-05-29
2029-05-29
Common Stock
30000
0
D
The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $14.87 to $15.31. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
/s/ Alane P. Barnes, by power of attorney
2021-09-14